Inhibiting proliferation of arterial smooth muscle cells
US6281225A · kind A · utility
65Cited by
10References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 10, 1999 |
| Grant date | Aug 28, 2001 |
| Priority date | — |
| Expiry date | Jun 10, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for inhibiting restenosis at a site of vascular recanalization. The methods include intravascular administration of a reactive acridine compound to the site of injury, without the requirement for activation or sustained release of the compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.